Evidence map›Paper›PMID 26993299›Full record

ArticleMolecular neurobiology2017

MicroRNA-27a Promotes Inefficient Lysosomal Clearance in the Hippocampi of Rats Following Chronic Brain Hypoperfusion.

Hui Che, Yan Yan, Xiao-Hui Kang, Fei Guo, Mei-Ling Yan, Huai-Lei Liu, Xu Hou, Tong Liu, De-Kang Zong, Lin-Lin Sun and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Ambiguous Effects of Autophagy Activation Following Hypoperfusion/Ischemia.International journal of molecular sciences · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Hui CheDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Yan YanDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Xiao-Hui KangDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Fei GuoDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Mei-Ling YanDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Huai-Lei LiuDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150001, China.
Xu HouDepartment of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150001, China.
Tong LiuDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
De-Kang ZongDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Lin-Lin SunDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Ya-Nan BaoDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Li-Hua SunDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Bao-Feng YangDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China.
Jing AiDepartment of Pharmacology, Harbin Medical University (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), No.157 Baojian Road, Nangang District, Harbin, Heilongjiang Province, 150086, China. azhrbmu@126.com.
Harbin Medical University · CNFirst Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic brain hypoperfusion (CBH) induces the accumulation of abnormal cellular proteins, accompanied by cognitive decline, and the autophagic-lysosomal system is abnormal in dementia. Whether CBH accounts for autophagic-lysosomal neuropathology remains unknown. Here, we show that CBH significantly increased the number of autophagic vacuoles (AVs) with high LC3-II levels, but decreased SQSTM1 and cathepsin D levels in the hippocampi of rats following bilateral common carotid artery occlusion (2VO) for 2 weeks. Further studies showed that microRNA-27a (Mir27a) was upregulated at 2 weeks compared with the sham group. Additionally, LAMP-2 proteins were downregulated by Mir27a overexpression, upregulated by Mir27a inhibition, and unchanged by binding-site mutations or miR-masks, indicating that lamp-2 is the target of Mir27a. Knockdown of endogenous Mir27a prevented the reduction of LAMP-2 protein expression as well as the accumulation of AVs in the hippocampi of 2VO rats. Overexpression of Mir27a induced, while the knockdown of Mir27a reduced, the accumulation of AVs and the LC3-II level in cultured neonatal rat neurons. The results revealed that CBH in rats at 2 weeks could induce inefficient lysosomal clearance, which is regulated by the Mir27a-mediated downregulation of LAMP-2 protein expression. These findings provide an insight into a novel molecular mechanism of autophagy at the miRNA level.

Indexed as

AnimalsAutophagyBase SequenceBrain IschemiaChronic DiseaseDown-RegulationHippocampusLysosomal-Associated Membrane Protein 2LysosomesMaleMicroRNAsMicrotubule-Associated ProteinsPhagosomesRats, Sprague-DawleyRibosomal Protein S6 Kinases, 70-kDaSequestosome-1 ProteinAnxa3 protein, ratLysosomal-Associated Membrane Protein 2MicroRNAsMicrotubule-Associated ProteinsMIRN27 microRNA, ratRibosomal Protein S6 Kinases, 70-kDaSequestosome-1 ProteinSqstm1 protein, ratAutophagyChronic brain hypoperfusionLAMP-2LysosomeMir27a

Identifiers

PMID26993299
OpenAlexW2309013017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.